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Development of the cerebral cortex depends partly on neural activity, but the identity of 
the ion channels that might contribute to the activity-dependent cortical development is 
unknown. KCNK channels are critical determinants of neuronal excitability in the 
mature cerebral cortex, and a member of the KCNK family, KCNK9, is responsible for a 
maternally transmitted mental retardation syndrome. Here, we have investigated the 
roles of KCNK family potassium channels in cortical development. Knockdown of 
KCNK2, 9, or 10 by RNAi using in utero electroporation impaired the migration of 
late-born cortical excitatory neurons destined to become layer II/III neurons. The 
migration defect caused by KCNK9 knockdown was rescued by coexpression of 
RNAi-resistant functional KCNK9 mutant. Furthermore, expression of 
dominant-negative mutant KCNK9, responsible for the disease, and 
electrophysiological experiments demonstrated that ion channel function was involved 
in the migration defect. Calcium imaging revealed that KCNK9 knockdown or 
expression of dominant-negative mutant KCNK9 increased the fraction of neurons 
showing calcium transients and the frequency of spontaneous calcium transients. 
Mislocated neurons seen after KCNK9 knockdown stayed in the deep cortical layers, 
showing delayed morphological maturation. Taken together, our results suggest that 




Neural activity plays roles in the formation of neural circuits (Katz and Shatz, 1996). In 
addition to its well-documented role in the refinement of circuits, some studies have 
shown that neural activity is also required for early neuronal development, including 
proliferation (Weissman et al., 2004; Liu et al., 2010), differentiation (Borodinsky et al., 
2004), and migration (Komuro and Rakic, 1993; Nakanishi and Okazawa, 2006; Manent 
and Represa, 2007; Bortone and Polleux, 2009). In the developing cerebral cortex of 
rodents, studies using extracellular recording and calcium imaging have demonstrated 
that the immature cortical neurons show characteristic patterns of activity (Khazipov 
and Luhmann, 2006; Allene and Cossart, 2010). Such activity is thought to influence 
cortical development. Hypo- or hyper-activity during development may induce 
abnormality in the cortical architecture, which might be the basis for some 
developmental disorders (Ross and Walsh, 2001; Ben-Ari, 2008). These roles of neural 
activity in multiple developmental stages suggest that controlling neuronal activity is 
vital for the proper development of immature neurons. 
The pattern of neural activity is regulated by ion channels. Developing cortical 
neurons express various ion channels, such as voltage-gated sodium channels, 
potassium channels, and calcium channels (Luhmann et al., 2000; Picken Bahrey and 
Moody, 2003). KCNK family leak potassium channels, which have four trans-membrane 
segments and two P-domains, are one of the major determinants of membrane potential 
(Goldstein et al., 2001). They conduct potassium current at resting membrane potential 
with little voltage-dependence, and are therefore called leak potassium channels. 
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KCNK channels are critical determinants of neuronal excitability in the cortex 
(Goldstein et al., 2001; Day et al., 2005). In addition, a member of the KCNK family, 
KCNK9 (TASK3), is responsible for a maternally transmitted developmental disorder, 
Birk Barel mental retardation dysmorphism syndrome (Barel et al., 2008), and KCNK9 
knockout mice show abnormalities in some cognitive functions such as working memory 
and spatial learning (Linden et al., 2007). Several members of the KCNK family 
(KCNK9, KCNK2/TREK1 and KCNK10/TREK2) are expressed in the developing 
cerebral cortex (Talley et al., 2001; Aller and Wisden, 2008). These facts imply that 
KCNK9 is involved in cortical function, and might also be involved in the formation of 
cortical neural circuits. However, whether dysfunction of KCNK9 affects cortical 
development has not yet been explored. In this study, we addressed this issue, and 
found that knockdown of KCNK9 expression by RNAi affected migration of cortical 
neurons. Functional blockade of KCNK9 by overexpression of a dominant-negative, 
disease-associated mutant channel (Barel et al., 2008) also disturbed this migration. 
KCNK9 knockdown neurons showed more frequent calcium transients than control 
neurons. These results suggest that KCNK potassium channels contribute to the 
migration of cortical pyramidal neurons through stabilization of intracellular calcium 
concentration. 
 
Material and Methods 
Animals  
Wild-type ICR mice were used in all experiments. The experimental procedures were 
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performed in accordance with the guidance for animal experimentation by the United 
States National Institutes of Health and Kyoto University, and were approved by the 
local committee for handling experimental animals in the Graduate School of Science, 
Kyoto University. 
 
Plasmid construction  
KCNK2, 9, and 10 shRNAs were obtained from Open Biosystems. Each shRNA was 
inserted into a pCAGmir30 vector (Matsuda and Cepko, 2007). The sequences of 
KCNK9 shRNA2 and 3 were designed using the Hannon lab web site 
(http://cancan.cshl.edu/RNAi_central/main2.cgi), and were inserted into a pSuper vector 
under the H1 promoter (OligoEngine). The sequences of shRNAs used in this study are 
shown in Supplementary Table S1. The numbers of shRNAs initially obtained were 1 
for KCNK2, 4 for KCNK9, and 1 for KCNK10. One KCNK9 shRNA did not effectively 
reduce the expression of KCNK9 protein in HEK293T cells, and therefore was not used 
for futher experiments. Mouse cDNA encoding KCNK9 was isolated from a cDNA 
library of adult mouse cortex by polymerase chain	 reaction. Mouse cDNAs encoding 
KCNK2 and 10 were purchased from Open Biosystems. Mutant and N-terminal 
EGFP-tagged KCNK channels were cloned into a pCAGplay vector (Kawaguchi and 
Hirano, 2006). For western blot, EGFP was fused to N-terminus of each KCNK channel 
with a linker (Gly-Ser-Ala). The pCAsalEGFP vector (Horikawa and Takeichi, 2001) 
was used for expression of enhanced green fluorescent protein (EGFP). GCaMP3 cDNA 
was purchased from Addgene (plasmid 22692), and inserted into pCAGplay vector. The 
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sequences of primers used to obtain mutant and EGFP-tagged KCNK channels are 
shown in Supplementary Table S3. 
 
In situ  hybridization.  
In situ hybridization was performed as previously described (Tagawa et al., 2005; 
Watakabe et al., 2007). KCNK2, 9, and 10 cDNAs were cut by restriction enzymes 
(KCNK2, BamHI/HincII; KCNK9, PstI; KCNK10, BamHI/PstI), and subcloned into 
pBluescript. Digoxogenin (DIG)-labeled RNA probes were transcribed by T3 or T7 RNA 
polymerases. Embryonic and neonatal mouse brains were cryoprotected in OCT 
compound (Sakura), and coronal sections of 20 µm were cut on a cryostat CM1850 
(Leica). The sections were fixed with 4 % paraformaldehyde for 10 min at room 
temperature, followed by washing twice in 2x SSC for 3 min at room temperature. The 
sections were incubated with 0.1 M triethanolamine for 3 min, and then acetic 
anhydride was added and the sections were incubated for 10 min at room temperature. 
The sections were hybridized with DIG-labeled RNA probes for 40 hr at 65 ? in 
hybridization solution (50 % formamide, 5x SSC, 5x Denhardt’s solution, 50 ng/ml yeast 
tRNA), followed by washing with 2x SSC for 30 min at 65 ?, 0.5x SSC for 15 min at 
65 ? and 0.5x SSC for 15 min at room temperature. The sections were incubated with 
alkaline phosphatase-conjugated anti-DIG (Roche) at 4 ? overnight. The hybridization 
signal was detected with TSA-plus Fluorescein System (Perkin Elmer) for 10 min at 




In utero  electroporation  
In utero electroporation was performed as reported previously (Saito and Nakatsuji, 
2001; Tabata and Nakajima, 2001; Mizuno et al., 2007). In brief, ICR mice at E15 were 
anesthetized with Somnopentyl (50 mg/kg, Kyoritsu Pharmacy), and their uteruses 
were exposed. Plasmid vectors were prepared at 0.2 mg/ml (KCNK9*, G95E, G95E*, 
G236R, G236R*), 0.5 mg/ml (GCaMP3) or 1.0 mg/ml (others) with Trypan Blue (Sigma), 
and 1 ~ 2 µl DNA solution was injected into the right lateral ventricle. Next, five electric 




Neonatal (P0 ~ 5) and juvenile (P10, 15 and 35) mice were deeply anesthetized. Brains 
were fixed with 4 % paraformaldehyde in phosphate buffer at 4 ?  overnight, 
transferred to 30 % sucrose in phosphate buffered saline (PBS), and incubated at 4 ? 
overnight. Neonatal brains were cryoprotected in OCT compound (Sakura), and coronal 
sections of 50 µm were cut on a cryostat CM1850 (Leica). Fifty-micrometer-thick coronal 
sections of juvenile brains were cut on a freezing microtome LM2000R (Leica). 
   Immunohistochemistry was performed using a free-floating procedure. The sections 
were incubated with blocking solution (5 % normal goat serum (Sigma), 0.2 % Triton 
X-100 in PBS) for 1 hr at room temperature, followed by incubation with primary 
antibodies in blocking solution at 4 ? overnight. Subsequently, the sections were 
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incubated with secondary antibodies for 1 hr at room temperature. The sections were 
mounted with Vectashield containing DAPI (Vector). The following primary and 
secondary antibodies were used: anti-GFP (chick, polyclonal, 1:600, Millipore), 
anti-Cux1 (rabbit, polyclonal, 1:100, Santa Cruz Biotechnology), Ctip2 (rat, monoclonal, 
1:600, Abcam), anti-Tbr1 (rabbit, polyclonal, 1:600, Abcam), anti-Ki67 (rabbit, 
monoclonal, 1:1000, Thermo Scientific), anti-Nestin (mouse, monoclonal, 1:600, BD 
Pharmingen), anti-KCNK3 (1 mg/ml, Alomone Labs), Alexa 488-conjugated anti-chick 
IgG, Alexa 568-conjugated anti-rabbit IgG, anti-mouse IgG, and anti-rat IgG (made in 
goat, 1:1000, Molecular Probes). 
 
Detection of apoptosis with TUNEL assay  
Apoptosis was detected with an ApopTag® Red In Situ Apoptosis Detection Kit 
(Chemicon). The experimental procedure was based on the protocol that was provided 
by the manufacturer. Briefly, 50-µm-thick coronal cortical sections were incubated with 
ethanol/acetic acid for 5 min at room temperature. Sections were incubated with TdT 
enzyme and DIG-labeled dNTP for 30 min at 37 ? . Subsequently, sections were 
incubated with rhodamine-conjugated anti-DIG antibody for 30 min at room 
temperature. Finally, sections were mounted with Vectashield containing DAPI 
(Vector). 
 
Microscopy and morphological analysis  
Fluorescent images were acquired on a confocal laser-scanning microscope FV1000 
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(Olympus). For acquisition of images of in situ hybridization and analysis of neuronal 
migration, a 10x dry objective was used. Images of a single confocal plane were acquired 
for in situ hybridization. Confocal images of 50-µm-thick z-stacks were acquired for 
analysis of neuronal migration, and the z-series of images were projected onto two 
dimensional representations. The fraction of EGFP-positive neurons in each layer was 
calculated by dividing the number of EGFP-positive neurons in each cortical layer by 
that of total EGFP-positive neurons in the cortex. At least 10 sections (one section per 
mouse) for each experimental condition were analyzed. 
   For acquisition of images to analyze the cell fate, proliferation, apoptosis and 
dendritic morphology, a 20x dry objective was used. Images of a single confocal plane 
were acquired for analysis of cell fate, proliferation and apoptisis, and z-series of images 
were obtained for morphological analysis. Z-series of images were projected onto 
two-dimensional planes. Dendrites were traced, and total length and branch points 
were analyzed with NeuronJ software (Meijering et al., 2004) (http://rsb.info.nih.gov/ij/). 
At least 5 neurons from one mouse were analyzed. 
Statistical analysis was performed with Student’s t-test or the Dunnett test. All 
results were expressed as mean ? SEM. 
 
Western blotting  
Plasmids encoding EGFP-tagged KCNK2, 9, 10, KCNK9*, G95E* or G236R* with or 
without shRNA expression vectors (2 µg for each) were transfected into HEK293T cells 
with Lipofectamine 2000 (Invitrogen), based on the protocol that was provided by the 
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manufacturer. Twenty-four hours after transfection, the cells were lysed in sample 
loading buffer (50 mM Tris-HCl, 4 % SDS, 20 % glycerol, 10 mM dithiothreitol, 0.001 % 
bromophenol blue), and were denatured for 30 minutes at 37 ?. The samples were 
separated by 10 % SDS-PAGE, and transferred onto nitrocellulose membranes. The 
membranes were incubated with blocking solution (5 % skim milk and 0.1 % Tween-20 
in TBS) for 1 hour at room temperature, and incubated with primary antibody (mouse 
monoclonal anti-GFP, 1:1000, Nacalai Tesque; mouse monoclonal anti-β-actin, 1:1000, 
Sigma) in blocking solution overnight at 4 ?. The membranes were incubated with 
HRP-conjugated secondary antibody (donkey monoclonal anti-mouse IgG, 1:1000, 
Molecular Probes) in TBS for 1 hour at room temperature. Signals were detected with 




Electrophysiological experiments were performed as previously described (Ohtsuki et al, 
2004). In brief, neonatal mouse brains were removed, and coronal 300 µm thick cortical 
slices were cut on a vibratome (linear slicer PRO 7, Dosaka EM) in chilled RDS solution 
(130 (mM) NaCl, 4.5 KCl, 2 CaCl2, 33 glucose and 5 HEPES). Slices were recovered for 
longer than 1 hour in Krebs’ solution saturated with 95 % O2 and 5% CO2 (124 (mM) 
NaCl, 26 NaHCO3, 1.8 KCl, 1.24 KH2PO4, 2.5 CaCl2, 1.3 MgCl2 and 10 glucose) at room 
temperature. Oxygenized Krebs’ solution was used as extracellular bath solution. The 
glass patch pipettes of 4 ~ 7 MΩ were used for recording. The patch pipettes were filled 
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with the internal solution (140 (mM) D-glucuronic acid, 7 KCl, 155 KOH, 5 EGTA, 10 
HEPES, 2 Mg-ATP and 0.2 Na-GTP). The junction potential was offset. Whole-cell 
recordings from migrating neurons in intermediate zone of P1 cortex were performed at 
room temperature (22 ~ 24 ?) with a patch clamp amplifier (EPC 9 or 10, HEKA). In 
voltage clamp experiments, the membrane potential was held at -60 mV. Input 
resistance was measured by applying -20 mV voltage pulses, and voltage-dependent 
inward and outward currents were recorded by applying positive voltage pulses with a 
10 mV step. Resting potential was recorded in a current clamp condition. Statistical 
analysis was performed with Student’s t-test. All results were expressed as mean ? 
SEM. 
 
Calcium imaging  
GCaMP3 cDNA with control, KCNK9 shRNA, or KCNK9 G236R were transfected by in 
utero electroporation. Coronal 500-µm-thick cortical slices of P1 mice were cut on a 
vibratome in chilled RDS solution. Slices were allowed to recover for longer than 1 hour 
in Krebs’ solution saturated with 95 % O2 and 5% CO2 at room temperature. Krebs’ 
solution was used as extracellular solution. Optical recording was performed at room 
temperature, using a fluorescent microscope BX50WI (Olympus) with a 20x 
water-immersion objective and an EM-CCD camera C9100 (Hamamatsu Photonics). 
The sampling rate was 1 Hz. The mean fluorescent signal of a single cell was calculated, 
and divided by that at the start using Aquacosmos software (Hamamatsu Photonics). A 
fluorescence change of 5 % above the baseline within 30 sec was regarded as a calcium 
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transient. Statistical analysis was performed with the χ2-test or Dunnett test. All 
results were expressed as mean ? SEM. 
 
Results 
Expression pattern of KCNK potassium channels in developing cortex 
Previous studies showed the expression of KCNK2, KCNK9 and KCNK10 in the 
developing cortex (Aller and Wisden, 2008), but their laminar distributions were 
unclear. As a first step to study the roles of KCNK potassium channels in cortical 
development, we examined the expression patterns of these potassium channels in the 
developing cortex by in situ hybridization. 
[Figure 1 here] 
KCNK2 was expressed in the cortical plate (CP), intermediate zone (IZ), 
subventricular zone (SVZ) and ventricular zone (VZ) at embryonic day 15 (E15) and E17. 
At postnatal day 0 (P0), KCNK2 was strongly expressed in the marginal zone (MZ), IZ, 
SVZ, VZ, and lower CP, but not in upper CP. It was expressed in layers I, V and VI, but 
was not expressed in layers II/III or IV at P3 (Fig. 1A). KCNK9 was expressed in MZ, 
CP, IZ, SVZ and VZ at E15 and 17. At P0 and 3, KCNK9 was expressed in all cortical 
layers except layer I. The expression level of KCNK9 in CP increased after birth (Fig. 
1B). KCNK10 was most highly expressed at E15. KCNK10 was strongly expressed in 
MZ, IZ, SVZ and VZ, and was weakly expressed in CP. At P0, KCNK10 was expressed 
in MZ, lower CP, IZ, SVZ and VZ. KCNK10 was weakly expressed in the lower cortical 
layers at P3 (Fig. 1C). Taken together, these findings indicate that KCNK2, 9, and 10 
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were expressed in SVZ and VZ at E15, and in IZ, SVZ and VZ at E17 and P0, suggesting 
that developing cortical neurons, including layer II/III neurons, express these KCNK 
potassium channels in the late embryonic and early postnatal stages. 
 
Neuronal migration was impaired by knockdown of KCNK potassium 
channels 
To determine whether KCNK potassium channels are involved in the cortical 
development, we performed RNAi experiments using in utero electroporation. Short 
hairpin RNAs (shRNAs) targeting KCNK2, 9 and 10 effectively inhibited the expression 
of each KCNK channel protein in HEK293T cells, whereas control shRNA did not affect 
the translation of mRNAs for these genes (Fig. 2A). A mutant variant of KCNK9 shRNA 
was used as a control shRNA (Supplementary Table S1). 
[Figure 2 here] 
The control or KCNK channel shRNA was then transfected into cortical layer II/III 
progenitor cells together with EGFP. Coronal cortical sections including visual, 
auditory, or somatosensory cortices were prepared at P0, 3 and 5, and the distribution of 
EGFP-positive neurons was examined. At P0, about half of EGFP- and control 
shRNA-expressing neurons were observed in IZ, SVZ, and VZ, and some EGFP-positive 
neurons were observed in the upper CP. The distributions of EGFP-positive neurons 
were not altered by knockdown of KCNK channels at P0 (Fig. 2B,C, Supplementary 
Table S2). Most neurons expressing control shRNA had arrived at the superficial layer 
by P3 (Fig. 2B,C, Supplementary Table S2, 83.4 ? 5.1 %, n = 11 sections). In contrast, 
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only a fraction of neurons expressing KCNK channel shRNAs reached layer II/III at P3 
(Fig. 2B,C, Supplementary Table S2, KCNK2 shRNA, 40.7 ? 2.3 %, n = 11, P < 0.001, 
Dunnett test; KCNK9 shRNA, 24.5 ? 2.1 %, n = 10, P < 0.001; KCNK10 shRNA, 47.7 
? 4.5 %, n = 11, P < 0.001). A decrease in the fraction of neurons in IZ/SVZ/VZ between 
P0 and P3 was small in KCNK knockdown mice (Fig. 2B,C, Supplementary Table S2, 
control shRNA P0, 52.3 ? 2.7 %, n = 12; P3, 10.1 ? 3.6 %, n = 11; KCNK2 shRNA P0, 
50.3 ? 3.0 %, n = 11; P3, 41.9 ? 2.3 %, n = 11; KCNK9 shRNA P0, 46.2 ? 2.1 %, n = 
11; P3, 47.1 ? 4.3 %, n = 10; KCNK10 shRNA P0, 47.5 ? 1.5 %, n = 12; P3, 39.8 ? 
3.8 %, n = 11), suggesting that an invasion into the cortical plate was decelerated by 
knockdown of KCNK channels. At P5, some neurons expressing KCNK9 shRNA still 
remained in deep cortical layers (Fig. 2B,C, Supplementary Table S2, Control shRNA, 
3.6 ? 1.3 %, n = 14; KCNK2 shRNA, 1.9 ? 0.6 %, n = 12, P = 0.698, Dunnett test; 
KCNK9 shRNA, 9.8 ? 1.8 %, n = 10, P = 0.002; KCNK10 shRNA, 2.3 ? 1.1 %, n = 12, 
P = 0.858) and white matter (Fig. 2B,C, Supplementary Table S2, Control shRNA, 10.4 
? 3.7 %, n = 14; KCNK2 shRNA, 8.3 ? 3.1 %, n = 12, P = 0.977, Dunnett test; KCNK9 
shRNA , 38.0 ? 2.3 %, n = 10, P < 0.001; KCNK10 shRNA, 8.2 ? 2.7 %, n = 12, P = 
0.975), but most EGFP-positive neurons expressing KCNK2 or 10 shRNA had reached 
superficial layer (Fig. 2B,C, Supplementary Table S2, Control shRNA, 86.0 ? 4.6 %, n 
= 14; KCNK2 shRNA, 89.9 ? 3.5 %, n = 12, P = 0.872, Dunnett test; KCNK9 shRNA 
52.2 ? 2.4 %, n = 10, P < 0.001; KCNK10 shRNA, 89.5 ? 2.6 %, n = 12, P = 0.906). 
Thus, knockdown of KCNK2, 9 or 10 impaired neuronal migration at P3, but only 
KCNK9 knockdown significantly impaired neuronal migration at P5. Knockdown of 
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these three members of KCNKs (KCNK2, 9 and 10) together impaired neuronal 
migration as severely as KCNK9 knockdown (Fig. 2B,C, Supplementary Table S2, P5, 
Layer II/III, 54.8 ? 4.2 %, P < 0.001; Layers IV-VI, 13.8 ? 1.7 %, P < 0.001; WM, 31.5 
? 4.4 %, P < 0.001, compared with control shRNA, n = 14). These results suggest that 
KCNK family leak potassium channels are involved in the migration of cortical layer 
II/III neurons. We focused on the function of KCNK9 in neuronal migration and 
performed further analysis of it, because knockdown of KCNK9 most clearly impaired 
neuronal migration. 
[Figure 3 here] 
 
Ion channel function of KCNK9 was required for neuronal migration 
We next confirmed that the impairment of migration by KCNK9 shRNA expression was 
not caused by an off-target effect. Two other shRNAs for KCNK9, whose target 
sequences were different from that of KCNK9 shRNA, also inhibited the expression of 
KCNK9 (Fig. 3A). These shRNAs impaired neuronal migration, like KCNK9 shRNA 
(Fig. 3B,C, Supplementary Table S2, layer II/III, pSuper, 94.1 ? 1.3 %, n = 12 sections; 
KCNK9 shRNA2, 18.3 ? 1.4 %, n = 11, P < 0.001, Dunnett test; KCNK9 shRNA3, 28.8 
? 1.6 %, n = 11, P < 0.001). Next, we attempted to rescue the phenotype by expressing 
mutant KCNK that was resistant to shRNA. We introduced mutations that disrupted 
the target sequence of KCNK9 shRNA but that did not alter the amino acid sequence. 
Indeed, the expression of this mutant KCNK9 (KCNK9*) was not inhibited by KCNK9 
shRNA (Fig. 3D). The impairment of neuronal migration was partially rescued by 
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co-expression of KCNK9* with KCNK9 shRNA (KCNK9 rescue) at P3 (Fig. 3E,F, 
Supplementary Table S2, Layer II/III, KCNK9 shRNA, 35.9 ? 2.7 %, n = 11 sections; 
KCNK9 rescue, 65.4 ? 3.0 %, n = 11, P < 0.001, Dunnett test). These results suggest 
that the impairment of neuronal migration was caused by knockdown of KCNK9. 
[Figure 4 here] 
   To examine further the role of KCNK9 in neuronal migration, we used two KCNK9 
mutant channels. Previous studies showed that glycine 95 at the potassium-selective 
filter and glycine 236 at the ion channel pore are crucial for the ion channel function of 
KCNK9. The mutants G95E and G236R are nonfunctional when expressed alone, and 
act as dominant-negative proteins when expressed with the wild-type channel (Pei et al., 
2003; Barel et al., 2008) (Fig. 4A). We performed electroporation with these mutant 
channels. Neuronal migration was impaired at P3 by the expression of these 
dominant-negative mutants (Fig. 4B,C, Supplementary Table S2, Layer II/III, EGFP, 
84.6 ? 3.6 %, n = 10; G95E, 54.6 ? 3.4 %, n = 12, P < 0.001, Dunnett test; G236R, 
38.5 ? 1.1 %, n = 11, P < 0.001). This result supported our findings from RNAi 
experiments and suggested that the expression and/or function of KCNK9 were critical 
for neuronal migration. 
   The crucial role of channel function of KCNK9 in the migration was suggested by 
another set of experiments. As mentioned above, migration defect caused by KCNK9 
knockdown could be rescued by coexpression of RNAi-resistant functional KCNK9 
(KCNK9*) channel (Fig. 3E,F, Supplementary Table S2). However, migration defect 
caused by KCNK9 knockdown was not recovered by coexpression of RNAi-insensitive 
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nonfunctional G95E or G236R mutant (Fig. 4E,F, Supplementary Table S2). Thus, the 
ion channel function of KCNK9 is necessary for the normal neuronal migration. 
   [Figure 5 here] 
   The requirement for ion channel function of KCNK9 for neuronal migration suggests  
that knockdown of KCNK9 might have altered electrophysiological properties of 
migrating neurons. It was shown that KCNK9 is critically involved in the regulation of 
resting membrane potential in cerebellar granule neurons (Brickley et al., 2007). We 
performed whole-cell patch-clamp recording from migrating cortical neurons expressing 
control shRNA or KCNK9 shRNA. Knockdown of KCNK9 significantly increased input 
resistance (Fig. 5A,B, control shRNA, 3.3 ? 0.7 GΩ, n = 16 neurons; KCNK9 shRNA, 
9.7 ? 2.0 GΩ, n = 17 neurons, P = 0.004, Student’s t-test). KCNK9 knockdown also 
significantly depolarized the resting membrane potential (Fig. 5C, control shRNA, -58.2 
? 5.1 mV, n = 16 neurons; KCNK9 shRNA, -40.9 ? 3.1 mV, n = 17 neurons, P = 0.007, 
Student’s t-test). On the other hand, KCNK9 knockdown did not affect the 
voltage-dependent transient inward current (control shRNA, -90.1 ? 24.6 pA, n = 16 
neurons; KCNK9 shRNA, -91.8 ? 21.3 pA, n = 17 neurons at -10 mV, P = 0.960, 
Student’s t-test) or sustained outward current (control shRNA, 197 ? 27.8 pA, n = 16 
neurons; KCNK9 shRNA, 159 ? 11.2 pA, n = 17 neurons at 0 mV, P = 0.227, Student’s 
t-test) induced by depolarizing voltage steps (Fig. 5D-F).  These results are consistent 
with the known roles of KCNK channels (Goldstein et al., 2001) and suggest that 




[Figure 6 here] 
Down-regulation of KCNK9 increased the frequency of spontaneous calcium 
transients 
Neuronal migration is partly regulated by intracellular calcium (Zheng and Poo, 2007). 
We thought that KCNK9 knockdown or functional blockade might alter the pattern of 
spontaneous calcium transients. To test this, we transfected a genetically encoded 
calcium indicator, GCaMP3 (Tian et al., 2009), with control, KCNK9 shRNA or a 
dominant-negative mutant, G236R, and performed calcium imaging from migrating 
neurons at P0/P1 (Fig. 6). A small fraction (about 10 %) of neurons expressing control 
shRNA showed calcium transients at a frequency of about 1 event/10min (Fig. 6A,B). 
We compared the pattern of spontaneous calcium transients between control and 
KCNK9 knockdown neurons in both IZ and lower CP. The fraction of neurons 
expressing KCNK9 shRNA that showed calcium transients was more than that of 
control neurons at P1 (P0 IZ, control shRNA, 7.1 %, 18/254 neurons; KCNK9 shRNA, 
11.7 %, 15/128 neurons, P = 0.128, χ2-test; P0 lower CP, control shRNA, 10.7 %, 15/140 
neurons; KCNK9 shRNA, 12.6 %, 27/214 neurons, P = 0.588; P1 IZ, control shRNA, 
11.0 %, 19/173 neurons; KCNK9 shRNA, 25.5 %, 39/153 neurons, P < 0.001; P1 lower CP, 
control shRNA, 9.2 %, 7/76 neurons; KCNK9 shRNA, 25.2 %, 37/147 neurons, P = 0.005). 
At P0, the frequency of spontaneous calcium transients in KCNK9 knockdown neurons 
was higher than that in control neurons in IZ, but not in lower CP (Fig. 6A,B, IZ, control 
shRNA, 1.2 ? 0.1 events/10 min, n = 18 neurons; KCNK9 shRNA, 2.7 ? 0.7 events/10 
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min, n = 15 neurons, P = 0.024, Student’s t-test; lower CP, control shRNA, 1.3 ? 0.1 
events/10 min, n = 15 neurons; KCNK9 shRNA, 1.6 ? 0.2 events/10 min, n = 27 
neurons, P = 0.191). At P1, the frequency of spontaneous calcium transients in KCNK9 
knockdown neurons was higher than that in control neurons both in IZ and lower CP 
(Fig. 6A,B, IZ, control shRNA, 1.3 ? 0.1 events/10 min, n = 19 neurons; KCNK9 
shRNA, 2.9 ? 0.5 events/10 min, n = 39 neurons, P = 0.002; lower CP, control shRNA, 
1.1 ? 0.1 events/10 min, n = 7 neurons; KCNK9 shRNA, 2.1 ? 0.2 events/10 min, n = 
37 neurons, P = 0.001, Student’s t-test). Thus, KCNK9 knockdown increased the 
frequency of spontaneous calcium transients in migrating cortical neurons. 
Is there any correlation between an increase in calcium transients and the migration 
defect? To test this, we carried out another set of experiments in which we compared the 
pattern of calcium transients in neurons expressing control shRNA, KCNK9 shRNA, or 
KCNK9 shRNA with RNAi-insensitive KCNK9 (KCNK9*) (Fig. 6C,D). The increase in 
the frequency of calcium transients caused by KCNK9 knockdown was partially 
“rescued” by coexpression of KCNK9* (Fig. 6C,D, KCNK9 rescue, fraction of neurons, 
47/138 neurons; frequency, 2.0 ? 0.2 events/10 min, n = 47 neurons, P = 0.012, 
compared with KCNK9 shRNA, P = 0.471, compared with control shRNA, Dunnett test). 
Thus, coexpression of RNAi-insensitive KCNK9 with KCNK9 shRNA partially restored 
both the pattern of calcium transients (Fig. 6C,D) and the migration phenotype (Fig. 
3E,F). 
We also examined effects of the expression of a disease-associated, 
dominant-negative mutant (G236R) of KCNK9. The fraction of neurons showing 
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calcium transients was significantly higher in dominant-negative mutant transfected 
mice (GCaMP3, 4.7%, 13/279 neurons, G236R, 33.9 %, 57/168 neurons, P < 0.001, 
χ2-test). Furthermore, the frequency of calcium transients was higher in neurons 
expressing G236R than in control neurons showing calcium transients (Fig. 6E,F, 
GCaMP3, 1.4 ? 0.2 events/10min, n = 13 neurons, G236R, 3.1 ? 0.3 events/10min, n 
= 57 neurons, P < 0.001, Student’s t-test). These results together suggest that 
dysfunction of KCNK9 influences the pattern of calcium transients in migrating 
neurons. 
 
Cell fate, neuronal proliferation, and apoptosis were not affected by 
knockdown of KCNK9 
Next we performed immunohistochemistry to examine whether the cell fate of neurons 
that failed to migrate was changed or not. Previous studies identified several genes 
expressed in a layer-specific manner, and some genes have been reported to be 
determinants of the neuronal subtype specification in the cerebral cortex (Molyneaux et 
al., 2007). Tbr1 is a determinant of corticothalamic neurons in layer VI, and preplate 
(Hevner et al., 2001). Ctip2 promotes the differentiation of layer V corticospinal motor 
neurons (Arlotta et al., 2005). Cux1 is expressed in layers II/III and IV, but is not 
expressed in the other layers (Nieto et al., 2004). 
[Figure 7 here] 
   Coronal cortical sections were stained with antibodies against Cux1, Ctip2 or Tbr1. 
Neurons expressing EGFP and control shRNA were Cux1-positive, consistent with 
 21 
previous studies (Fig. 7A). KCNK9 shRNA-expressing neurons that reached layer II/III 
were also Cux1-positive (Fig. 7B). KCNK9 shRNA-expressing neurons that failed to 
migrate also expressed Cux1, but did not express Ctip2 or Tbr1 (Fig.7B). These results 
suggest that cell fate specification is not affected by KCNK9 knockdown. 
Previous studies have shown a role of KCNK9 in the development of cerebellar 
granule neurons, in which this channel is highly expressed (Talley et al., 2001; Han et 
al., 2002) and involved in potassium-dependent apoptosis (Lauritzen et al., 2003). In 
addition, KCNK9 has been implicated in cell division in tumor cells (Mu et al., 2003; Pei 
et al., 2003). We performed immunostaining against Ki67, which is a marker for cell 
division, and TUNEL staining for detection of apoptotic cells at E17. The fraction of 
EGFP/Ki67-double-positive cells (Fig. 7C,D, control shRNA, 9.3 ?  1.2 %; KCNK9 
shRNA, 10.2 ? 1.9%, n = 12 sections for each, P = 0.691, Student’s t-test) and the 
number of TUNEL-positive cells (Fig. 7E,F, control shRNA, 5.3 ? 0.7 cells; KCNK9 
shRNA, 5.6? 0.8 cells, n = 12 sections for each, P = 0.755, Student’s t-test) were not 
significantly different between control and KCNK9 shRNA (Fig. 7C-F). In addition, 
immunostaining against Nestin showed that radial glial scaffold was not affected by 
KCNK9 knockdown (Fig. 7G). These results suggest that knockdown of KCNK9 does 
not affect neuronal proliferation, apoptosis and radial glial scaffold. 
 
[Figure 8 here] 
KCNK9 knockdown impeded morphological maturation 
What is the fate of neurons showing a migration defect during the neonatal period? Do 
 22 
they stay in deep cortical layers and mature, or eventually disappear? To answer these 
questions, we examined the laminar distribution of EGFP-positive neurons expressing 
KCNK9 shRNA at P10, 15 and 35. At P35, the fraction of EGFP-positive neurons in WM 
was slightly smaller than that at P10 (Fig. 8A,B, Supplementary Table S2, P10, 12.1 ? 
1.8 %, n = 11 sections; P15, 8.7 ? 2.0 %, n = 15, P = 0.322, Dunnett test: P35, 4.1 ? 
1.3 %, n = 10, P = 0.014), but the fraction of EGFP-positive neurons in layer II/III and 
layers IV-VI did not significantly differ among these ages (Fig. 8A,B, Supplementary 
Table S2, layer II/III, P10, 77.9 ? 2.7 %, n = 11; P15, 80.7 ? 2.4 %, n = 15, P = 0.635, 
Dunnett test; P35, 83.6 ? 2.4 %, n = 10, P = 0.243, layers IV-VI, P10, 10.0 ? 1.4 %; 
P15, 10.6 ? 1.1 %, P = 0.926; P35, 12.6 ? 1.3 %, P = 0.291). At P35, some of neurons 
in WM may have moved into the cortex, not have died, because the number of 
EGFP-positive cells did not significantly change among ages (P10, 146.0 ?  20.0 
neurons; P15, 133.0 ? 10.7 neurons P = 0.786, Dunnett test; P35, 152.5 ? 20.1 
neurons, P = 0.948). These results suggest that many of the mislocated neurons 
resulting from KCNK9 knockdown stay in deep cortical layers during development. At 
P10, many EGFP-positive neurons in deep cortical layers had apical protrusions with 
few branches, reminiscent of the leading process of typical migrating neurons (Fig. 
8C,F,G, branch points, 1.2 ? 0.3; total length, 287.3 ? 25.7 µm, n = 34 neurons). At 
P15, these neurons had some branched dendrites (Fig. 8D,F,G, branch points, 3.3 ? 
0.7, P = 0.019, Dunnett test; total length, 384.7 ? 42.5 µm, P = 0.348, n = 23 neurons), 
and at P35, they had complex dendritic arbors, similar to those of mature neurons (Fig. 
8E-G, branch points, 10.9 ? 0.8, P < 0.001; total length, 2081.0 ? 133.0 µm, P < 0.001, 
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n = 27 neurons). These observations suggest that dendritic maturation is delayed in 
neurons that failed to migrate due to KCNK9 knockdown, and that these neurons 
somehow mature by P35 in deep cortical layers. 
 
Discussion 
We have demonstrated that KCNK potassium channels, especially KCNK9, play an 
important role in neuronal migration in the developing cerebral cortex. Knockdown of 
KCNK9 in late-born cortical neurons by RNAi resulted in a migration defect. 
Expression of the dominant-negative mutant channel G236R, found in patients with an 
inherited mental retardation (Barel et al., 2008), also caused a migration defect in the 
cortex, suggesting that ion channel function is required for neuronal migration. 
Electrophysiological experiments showed that knockdown of KCNK9 depolarize resting 
membrane potential. Knockdown or functional blockade of KCNK9 with the 
dominant-negative mutant channel G236R increased the frequency of spontaneous 
calcium transients. Taken together, these results suggest that dysfunction of KCNK9 
impairs migration of cortical excitatory neurons in an activity-dependent mechanism. 
 
Dysfunction of KCNK9 can cause a migration defect in the cortex 
Our data, obtained from RNAi experiments using three independent shRNAs, rescue 
experiments, and functional blockade experiments using dominant-negative mutants, 
indicate that a deficit in the expression/function of KCNK9 can cause a migration defect 
in the cortex. Earlier studies reported that KCNK9 knockout mice showed abnormality 
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in some cognitive functions and in the regulation of cellular excitability in mature 
cerebellar granule neurons (Brickley et al., 2007; Linden et al., 2007). It is unclear 
whether migration of cortical excitatory neurons is impaired in KCNK9 knockout mice, 
because these studies did not focus on neuronal migration in the cortex. There are 
several cases where the extent of migration defects caused by genetic knockout is not 
comparable to that by in utero knockdown (Bai et al., 2003; Chen et al., 2008; Ip et al., 
2011), and in the genetic knockout mice, compensatory mechanisms by other family 
members have been suggested (Corbo et al., 2002; Deuel et al., 2006; Koizumi et al., 
2006). In utero knockdown can be a useful approach for identifying genetic factors 
responsible for abnormality in cortical development, and for further investigation on 
how loss-of-function of target molecules affects cortical neuron development.  
   Developing cortical neurons express several members of KCNK potassium channels 
(Aller and Wisden, 2008). When one of these (e.g. KCNK9) is knocked down, other 
members (e.g. KCNK2 and/or 10) may compensate for the reduced expression. However, 
we did not observe an additive effect of multiple knockdown: the distribution of 
EGFP-positive neurons in KCNK2/9/10 knockdown cortex was comparable to that in 
single knockdown of KCNK9 at P0, 3 and 5 (Fig. 2B, C, Supplementary Table S2). 
KCNK9 may play a dominant role in neuronal migration in the developing cortex. 
   It is reported that KCNK3 (TASK1) can form heterodimer with KCNK9 in cerebellar 
granule cells and motoneurons and modulate its ion channel function (Berg et al., 2004, 
Kang et al., 2004). There is a possibility that KCNK3 may be involved in 
KCNK9-dependent regulation of neuronal migration in the developing cerebral cortex. 
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However, a previous report has shown no or low expression of KCNK3 mRNA in the 
developing cerebral cortex (Aller and Wisden, 2008). Our immunohistochemical 
experiments using KCNK3-specific antibody (Toyoda et al., 2010) showed no apparent 
expression of KCNK3 in the developing cortex, and we did not observe compensatory 
up-regulation of KCNK3 expression in KCNK9 knockdown cortex (data not shown). 
 
KCNK9 contributes to neuronal migration through the regulation of 
spontaneous calcium transients 
How does dysfunction of KCNK9 impede migration? Our results suggest a possibility 
that downregulation of KCNK9 disturbed neuronal migration by increasing 
spontaneous calcium transients. Experiments using calcium imaging demonstrated 
that KCNK9 knockdown or expression of a disease-associated mutant (which behaves 
as a dominant-negative mutant) increased the frequency of calcium transients in 
migrating cortical neurons (Fig. 6). Coexpression of RNAi-insensitive KCNK9 with 
KCNK9 shRNA restored the pattern of calcium transients, and the migration 
phenotype. It is known that neuronal migration is in part regulated by neural activity 
and calcium signaling (Komuro and Rakic, 1998; Zheng and Poo, 2007), but 
activity-dependent mechanism of migration in cortical excitatory neurons has been 
elusive. We, as well as others, have shown that overexpression of Kir2.1 (a genetic tool 
to reduce neuronal excitability) in developing cortical excitatory neurons does not 
interfere with their migration (Cancedda et al., 2007; Mizuno et al., 2007). In the 
current study, we used in utero electroporation to express genetically-coded 
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calcium-sensitive indicator GCaMP3 specifically in migrating cortical neurons, and 
performed calcium imaging. The combination of in utero down-regulation of intrinsic 
ion channel and calcium imaging revealed that too frequent spontaneous calcium influx 
might impede neuronal migration in the developing cerebral cortex. 
   The increase of spontaneous calcium transients caused by KCNK9 knockdown is 
presumably mediated through depolarization of resting membrane potential as 
suggested by electrophysiological experiments (Fig. 5C). This phenotype of KCNK9 
knockdown is consistent with a previous study which reported ~10mV depolarization of 
resting membrane potential in cerebellar granule neurons of KCNK9 knockout mice 
(Brickley et al., 2007). Voltage-dependent sodium and calcium channels would have 
more chance to open at a depolarized membrane potential. The increased calcium influx 
may dysregulate downstream intracellular signaling and calcium-dependent gene 
expression critical for the proper control of migration (Nakanishi and Okazawa, 2006). 
   It has been shown that blockade of calcium transients through voltage-gated calcium 
channels and NMDA receptors impedes the migration of cerebellar granule neurons 
(Komuro and Rakic, 1992; 1993). Cortical interneuron migration is also sensitive to 
changes in the intracellular calcium concentration that are regulated by GABAA and 
AMPA/NMDA receptors (Bortone and Polleux, 2009). In both types of neuron, the 
frequency of calcium transients positively correlates with the rate of migration, and loss 
of calcium transients acts as a “stop” signal for migration (Komuro and Rakic, 1996; 
Kumada and Komuro, 2004; Bortone and Polleux, 2009). Our results seem contradictory 
to these previous results, because KCNK9 knockdown induced an increase, but not a 
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decrease, in the frequency of calcium transients, and suppressed neuronal migration. 
On the other hand, our results are consistent with a previous report that showed that in 
immature cortical neurons, interfering with calcium transients by blocking the 
excitatory action of GABA enhances migration (Heck et al., 2007). Their results and 
ours suggest that cortical excitatory neurons may differ from cerebellar granule 
neurons and cortical interneurons, in that they require relatively low-levels or low 
frequencies of calcium transients for proper migration. Similar cell-type specific effect of 
calcium transients on the motility has been reported in growing axons, where the 
frequency of calcium transients in growth cones are inversely or directly proportional to 
the rate of axonal outgrowth (Gomez and Spitzer, 1999; Hutchins et al., 2011). To 
further clarify the relationship between calcium transients and cell motility during 
migration of cortical excitatory neurons, a combination of calcium and time-lapse 
imaging would be useful in future. 
 
KCNK9 and developmental disorders 
A dominant-negative mutant of KCNK9 (G236R) was found in patients suffering from 
an inherited developmental disorder, Birk Barel mental retardation dysmorphism 
syndrome (Barel et al., 2008). In addition, it has been reported that KCNK9 knockout 
mice show abnormalities in some learning tasks (Linden et al., 2007). These studies 
support the notion that dysfunction of KCNK9 causes a developmental disorder. We 
found that dysfunction of KCNK9 disrupted neuronal migration in the developing 
cerebral cortex. This result suggests the possibility that suppressed neuronal migration 
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by KCNK9 dysfunction could be a cause of mental retardation. Indeed, migration 
defects are closely coupled with some developmental disorders in humans (Ross and 
Walsh, 2001; LoTurco and Bai, 2006; Ben-Ari, 2008). For instance, 
microtubule-associated proteins DCX and Lis1 are responsible for cortical 
malformations such as subcortical band heterotopia and lissencephally, and their 
knockdown in an animal model disrupts neuronal migration (Bai et al., 2003; Tsai et al., 
2005). Interestingly, in DCX knockdown cortex, heterotopic neurons located in the deep 
cortical layer and normally migrated layer II/III neurons form an abnormal neural 
network, and this abnormal network becomes a source of synchronous epileptogenic 
firings, reproducing some symptoms present in human patients (Ackman et al., 2009). 
We have shown that mislocated neurons, resulting from KCNK9 knockdown, stayed 
and slowly matured in the deep cortical layers in early postnatal period, which includes 
the period during which large-scale dynamic calcium transients and propagating waves 
have been observed in the cortex (Garaschuk et al., 2000; Khazipov and Luhmann, 
2006; Allene and Cossart, 2010). Dysfunction of KCNK9 may alter the pattern of such 
network activities, possibly through the regulation of excitability of individual neurons 
or the mislocated neurons abnormally integrated into the cortical circuits. 
In conclusion, we have demonstrated that KCNK potassium channels play roles in 
the migration of cortical excitatory neurons. KCNK potassium channels promote 
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Figure 1. A-C , Expression of KCNK potassium channels during cortical development. 
Representative images of in situ hybridization showing laminar expression patterns of 
KCNK2 (A), 9 (B), and 10 (C) in the developing mouse cortex from E15 to P3. D , DAPI 
staining shows the location of nuclei. Scale bar, 100 µm. MZ, marginal zone, CP, cortical 
plate, IZ, intermediate zone, SVZ, subventricular zone, VZ, ventricular zone. 
 
Figure 2. Migration impairment caused by knockdown of KCNK potassium channels. 
A , Immunoblotting showing the expression of KCNK channels. N-terminal 
EGFP-tagged KCNK channels were transfected with or without shRNA-expressing 
vectors in HEK293T cells. Immunoblotting of actin was performed as a loading control. 
B , Coronal sections of P0, 3, and 5 mouse brains showing the distribution of 
EGFP-labeled neurons across cortical layers. Representative images of visual cortex are 
presented. EGFP was electroporated at E15 with control or KCNK channel shRNAs. 
EGFP-expressing neurons are shown in green. Arrows indicate the neurons whose 
migration was impaired. Scale bar, 100 µm. uCP, upper cortical plate, lCP, lower 
cortical plate. C , Analysis of the laminar distribution of EGFP-positive neurons. Mean 
? SEM is presented. **, P < 0.01, ***, P < 0.001, Dunnett test, compared with control 
shRNA. 
 
Figure 3. The effects of other shRNAs targeting KCNK9 and rescue experiment. A , 
Immunoblotting showing the expression of KCNK9. N-terminal EGFP-tagged KCNK9 
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were transfected with or without shRNA expressing vectors in HEK293T cells. 
Immunoblotting of actin was done as a loading control. B , Coronal sections of P3 mouse 
brain. EGFP was electroporated at E15 with or without shRNAs targeting KCNK 
channels. Scale bar, 100 µm. C , Analysis of the laminar distribution of EGFP-positive 
neurons. Mean ? SEM is presented. ***, P < 0.001, Dunnett test, compared with 
pSuper. D , Immunoblotting showing the expression of shRNA-resistant mutant KCNK9 
(KCNK9*). N-terminal EGFP-tagged KCNK9* was transfected into HEK293T cells 
with or without KCNK9 shRNA. Immunoblotting of actin was performed as a loading 
control. E , Coronal cortical sections from P3 mice. KCNK9 shRNA, KCNK9 shRNA + 
KCNK9* (KCNK9 rescue), or KCNK9* was transfected at E15 with EGFP. F , Analysis 
of the distribution of EGFP-positive neurons across cortical layers. Mean ? SEM is 
presented. ***, P < 0.001, Dunnett test, compared with KCNK9 shRNA. Scale bar, 100 
µm. 
 
Figure 4. Requirement for ion channel function of KCNK9 for neuronal migration. A , 
The location of the dominant-negative mutations. B , P3 coronal sections of mice 
transfected with EGFP or EGFP plus a dominant-negative mutant. EGFP, EGFP + 
G95E, or EGFP + G236R was electroporated at E15. Scale bar, 100 µm. C , Laminar 
distribution of EGFP-positive neurons. Mean ? SEM is presented. ***, P < 0.001, 
Dunnett test, compared with EGFP. D , Immunoblotting showing the expression of 
shRNA-resistant non-functional mutants (G95E*, G236R*). N-terminal EGFP-tagged 
G95E* or G236R* was transfected into HEK293T cells with or without KCNK9 shRNA. 
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Immunoblotting of actin was performed as a loading control. E , P3 coronal sections of 
mice transfected with KCNK9 shRNA and an RNAi-resistant functional or 
non-functional KCNK9. KCNK9 shRNA + KCNK9* (KCNK9 rescue), KCNK9 shRNA + 
G95E*, or KCNK9 shRNA + G236R* was electroporated at E15. Scale bar, 100 µm. F , 
Laminar distribution of EGFP-positive neurons. Mean ? SEM is presented. ***, P < 
0.001, Dunnett test, compared with KCNK9 rescue. 
 
Figure 5. Electrophysiological properties of migrating neurons. 
A , Current changes induced by 80 ms hyperpolarizing pulses to -80 and -100 mV from 
the holding potential of -60 mV. B , The input resistances were calculated by dividing 
the amplitude of voltage pulses by the amplitude of steady current. Mean ? SEM is 
presented. **, P < 0.01, Student’s t-test. C , Resting membrane potential recording in a 
current clamp condition. **, P < 0.01, Student’s t-test. D , Representative current traces 
induced by 80 ms depolarizing voltage pulses from -60 mV. E ,F , Current-voltage 
relationship of the peak inward current (E) and sustained outward current (F). Mean 
? SEM is presented. 
 
Figure 6. Spontaneous calcium transients in migrating neurons. A , Representative 
time courses of F/F0 recorded from control or KCNK9 shRNA-expressing migrating 
neurons in IZ and lower CP at P0 and 1. B , The number of calcium transients during 
10-min recordings. Mean ? SEM is presented. *, P < 0.05, **, P < 0.01, Student’s t-test. 
C , Representative time courses of F/F0 recorded from control or KCNK9 shRNA, or 
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KCNK9 rescue-expressing migrating neurons in IZ at P1. D , The number of calcium 
transients during 10-min recordings. Mean ? SEM is presented. *, P < 0.05, N.S., not 
significant, Dunnett test. E , Representative time courses of F/F0 recorded from control 
or G236R-expressing migrating neurons in IZ at P1. F , The number of calcium 
transients during 10-min recordings. Mean ?  SEM is presented. ***, P < 0.001, 
Student’s t-test. 
 
Figure 7. Immunostaining for layer-specific markers, cell division, apoptosis, and 
radial glia. A ,B , Confocal images of P3 coronal sections stained with Cux1, Ctip2, and 
Tbr1 antibodies at P3. A , Images of EGFP-positive neurons expressing control shRNA 
in layer II/III. B , Images of EGFP-positive neurons expressing KCNK9 shRNA in layer 
II/III, layers IV-VI, and IZ/SVZ/VZ. Arrows indicate the layer-specific marker-positive 
neurons, and arrowheads indicate the marker-negative neurons. C ,E,G , 
Immunostaining for markers for proliferating cells (C), apoptosis (E), and radial glia 
(G) at E17. C , Immunostaining for Ki67, a marker for cells in M, G1, S, and G2 phases. 
Arrows indicate EGFP- and Ki67-double-positive cells. D , Quantification of 
EGFP-positive proliferating cells. The fraction of proliferating cells was calculated by 
dividing the number of EGFP- and Ki67-double-positive cells by that of total 
EGFP-positive cells in 200 µm square of IZ/SVZ/VZ. E , Staining of apoptotic cells with 
TUNEL method. Arrows indicate TUNEL-positive cells. F , Quantification of apoptotic 
cells. The number of TUNEL-positive cells was counted in 200 µm square of IZ/SVZ/VZ. 
G , Immunostaining for Nestin, a marker for radial glia. The structure of radial glial 
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scaffold was not altered by knockdown of KCNK9. Scale bar, A-C ,E , 100 µm. G , 50 µm. 
 
Figure 8. Morphological development of mislocated neurons. A , Coronal sections of 
P10, 15, and 35 mouse brain transfected with KCNK9 shRNA at E15. Scale bar, 100 µm. 
B , Laminar distribution of EGFP-positive neurons from P10 to P35. Mean ? SEM is 
presented. *, P < 0.05, Dunnett test, compared with P10. C-E , Confocal images of 
mislocated neurons during development (upper panel). Scale bar, 100 µm. Dendritic 
morphology of the mislocated neurons reconstructed with NeuronJ (lower panel). Scale 
bar, 200 µm. F , G , Developmental changes of branch points (F) and total length (G) of 
dendrites of mislocated neurons. Mean ? SEM is presented. *: P < 0.05, ***: P < 0.001, 







































Supplementary Table1. Sequences of KCNK channel shRNAs.
Construct Sequence
Control shRNA 5' CTCCTCAATCGTTAGATGA 3'
KCNK2 shRNA 5' GGCCATTAATGTTATGAAA 3'
KCNK9 shRNA 5' CTGCTGAAACGTATCAAGA 3'
KCNK10 shRNA 5' CAAACAGTTATGAAGTGGA 3'
KCNK9 shRNA2 5' GCGAGGAGGAGAAACTTAA 3'
KCNK9 shRNA3 5' GTCTCAGAGGCAAGTACAA 3'




Supplementary Table 2. Summary of analysis of neuronal migration.
Upper CP or Layer II/III Lower CP or Layers IV-VI IZ/SVZ/VZ or WM
Control shRNA 19.4 ± 2.5 28.3 ± 1.2 52.3 ± 2.7 12
KCNK2 shRNA 23.0 ± 2.7 (0.630) 26.7 ± 2.2 (0.905) 50.3 ± 3.0 (0.955) 11
KCNK9 shRNA 24.3 ± 2.1 (0.356) 29.5 ± 1.7 (0.964) 46.2 ± 2.1 (0.310) 11
KCNK10 shRNA 23.5 ± 1.8 (0.503) 29.0 ± 1.2 (0.992) 47.5 ± 1.5 (0.495) 12
KCNK2/9/10 shRNA 14.8 ± 2.0 (0.378) 30.4 ± 1.6 (0.756) 54.8 ± 3.2 (0.895) 13
Control shRNA 83.4 ± 5.1 6.5 ± 1.9 10.1 ± 3.6 11
KCNK2 shRNA 40.7 ± 2.3 (< 0.001) 17.4 ± 2.1 (< 0.001) 41.9 ± 2.3 (< 0.001) 11
KCNK9 shRNA 24.5 ± 2.1 (< 0.001) 28.4 ± 2.3 (< 0.001) 47.1 ± 4.3 (< 0.001) 10
KCNK10 shRNA 47.7 ± 4.5 (< 0.001) 12.6 ± 1.5 (0.081) 39.8 ± 3.8 (< 0.001) 11
KCNK2/9/10 shRNA 33.5 ± 2.1 (< 0.001) 20.7 ± 1.5 (< 0.001) 45.9 ± 3.0 (< 0.001) 14
Control shRNA 86.0 ± 4.6 3.6 ± 1.3 10.4 ± 3.7 14
KCNK2 shRNA 89.9 ± 3.5 (0.872) 1.9 ± 0.6 (0.698) 8.3 ± 3.1 (0.977) 12
KCNK9 shRNA 52.2 ± 2.4 (< 0.001) 9.8 ± 1.8 (0.002) 38.0 ± 2.3 (< 0.001) 10
KCNK10 shRNA 89.5 ± 2.6 (0.906) 2.3 ± 1.1 (0.858) 8.2 ± 2.7 (0.975) 12
KCNK2/9/10 shRNA 54.8 ± 4.2 (< 0.001) 13.8 ± 1.7 (< 0.001) 31.5 ± 4.4 (< 0.001) 14
pSuper 94.1 ± 1.3 2.0 ± 0.3 3.9 ± 1.3 12
KCNK9 shRNA2 18.3 ± 1.4 (< 0.001) 21.1 ± 2.6 (< 0.001) 60.6 ± 3.6 (< 0.001) 11
KCNK9 shRNA3 28.8 ± 1.6 (< 0.001) 27.1 ± 1.9 (< 0.001) 44.1 ± 2.3 (< 0.001) 11
KCNK9 shRNA 35.9 ± 2.7 22.1 ± 1.4 42.0 ± 3.3 11
KCNK9 rescue 65.4 ± 3.0 (< 0.001) 18.9 ± 2.5 (0.583) 15.6 ± 3.1 (< 0.001) 11
KCNK9* 65.8 ± 4.9 (< 0.001) 14.7 ± 3.3 (0.085) 19.4 ± 3.6 (< 0.001) 11
EGFP 84.6 ± 3.6 3.2 ± 0.9 12.2 ± 3.3 10
G95E 54.6 ± 3.4 (< 0.001) 13.5 ± 1.4 (< 0.001) 31.9 ± 3.4 (< 0.001) 12
G236R 38.5 ± 1.1 (< 0.001) 23.3 ± 2.0 (< 0.001) 38.1 ± 2.1 (< 0.001) 11
KCNK9 rescue 74.9 ± 2.7 13.3 ± 1.8 11.8 ± 1.9 13
shRNA + G95E* 35.4 ± 5.4 (< 0.001) 10.3 ± 1.3 (0.353) 54.3 ± 4.6 (< 0.001) 12
shRNA + G236R* 26.0 ± 1.7 (< 0.001) 13.7 ± 1.7 (0.982) 60.3 ± 2.3 (< 0.001) 12
P10 77.9 ± 2.7 10.0 ± 1.4 12.1 ± 1.8 11
P15 80.7 ± 2.4 (0.635) 10.6 ± 1.1 (0.926) 8.7 ± 2.0 (0.322) 15
P35 83.6 ± 2.4 (0.243) 12.6 ± 1.3 (0.291) 4.1 ± 1.3 (0.014) 10















Supplementary Table 3. Sequences of primers for cloning of KCNK channels.
Construct Direction Sequence
forward 5' GGGAATTCACCATGAAGCGGCAGAACGTGC 3'
reverse 5' CCGGATCCTTAGATGGACTTGCGACGGAGG 3'
forward 5' GGGAATTCACCATGAAGCGGCAGAACGTGC 3'
mutation reverse 5' AATTCTCTTTAATAAGTAGCGCACGAAGGT 3'
mutation forward 5' TTATTAAAGAGAATTAAAAAGTGCTGTGGC 3'
reverse 5' CCGGATCCTTAGATGGACTTGCGACGGAGG 3'
forward 5' GGGAATTCACCATGAAGCGGCAGAACGTGC 3'
mutation reverse 5' CAGTTCCAGGTGCAGCATGTCCATATTCGA 3'
mutation forward 5' TCGAATATGGACATGCTGCACCTGGAACTG 3'
reverse 5' CCGGATCCTTAGATGGACTTGCGACGGAGG 3'
forward 5' GGGAATTCACCATGAAGCGGCAGAACGTGC 3'
mutation reverse 5' ATTGAGGAAGGCACGGATGACGGTCAGGCC 3'
mutation forward 5' GGCCTGACCGTCATCCGTGCCTTCCTCAAT 3'
reverse 5' CCGGATCCTTAGATGGACTTGCGACGGAGG 3'
EGFP forward 5' CAGAATTCGCCACCATGGTGAGCAAGGGCG  3'
fusion reverse 5' TGCCGCTTCATTGCAGATCCCTTGTACAGC 3'
fusion forward 5' GCTGTACAAGGGATCTGCAATGAAGCGGCA 3'
KCNK9 reverse 5' CCGGATCCTTAGATGGACTTGCGACGGAGG 3'
EGFP forward 5' CCAAGCTTGCCACCATGGTGAGCAAGGGCG 3'
fusion reverse 5' GGGGCCGCCATTGCAGATCCCTTGTACAGC 3'
fusion forward 5' GCTGTACAAGGGATCTGCAATGGCGGCCCC 3'
KCNK2 reverse 5' CTCGAGCTACTTCATGTTCTCAATGACAGC 3'
EGFP forward 5' CCAAGCTTGCCACCATGGTGAGCAAGGGCG 3'
fusion reverse 5' GAAAAATACATTGCAGATCCCTTGTACAGC 3'
fusion forward 5' GCTGTACAAGGGATCTGCAATGTATTTTTC 3'
KCNK10 reverse 5' CTGTCGACTTAGTTTCTGTCTTCAAGTAAA 3'
EGFP-KCNK10
KCNK9
KCNK9*
KCNK9 G95E
KCNK9 G236R
EGFP-KCNK9
EGFP-KCNK2
